[HTML][HTML] Targeting PI3K/AKT signaling pathway in obesity

MS Savova, LV Mihaylova, D Tews, M Wabitsch… - Biomedicine & …, 2023 - Elsevier
Obesity is a disorder with an increasing prevalence, which impairs the life quality of patients
and intensifies societal health care costs. The development of safe and innovative …

[HTML][HTML] A comprehensive review on celastrol, triptolide and triptonide: Insights on their pharmacological activity, toxicity, combination therapy, new dosage form and …

J Song, GN He, L Dai - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Celastrol, triptolide and triptonide are the most significant active ingredients of Tripterygium
wilfordii Hook F (TWHF). In 2007, the 'Cell'journal ranked celastrol, triptolide, artemisinin …

A novel anti-osteoporosis mechanism of VK2: interfering with ferroptosis via AMPK/SIRT1 pathway in type 2 diabetic osteoporosis

C Jin, K Tan, Z Yao, B Lin, D Zhang… - Journal of Agricultural …, 2023 - ACS Publications
Type 2 diabetic osteoporosis (T2DOP) is a chronic bone metabolic disease. Compared with
traditional menopausal osteoporosis, the long-term high glucose (HG) microenvironment …

Celastrol in metabolic diseases: Progress and application prospects

S Xu, Y Feng, W He, W Xu, W Xu, H Yang, X Li - Pharmacological research, 2021 - Elsevier
Metabolic diseases are becoming increasingly common in modern society. Therefore, it is
essential to develop effective drugs or new treatments for metabolic diseases. As an active …

Natural products: Potential therapeutic agents to prevent skeletal muscle atrophy

A Yadav, SS Yadav, S Singh, R Dabur - European Journal of …, 2022 - Elsevier
The skeletal muscle (SkM) is the largest organ, which plays a vital role in controlling
musculature, locomotion, body heat regulation, physical strength, and metabolism of the …

Mitochondrial targeting therapeutics: promising role of natural products in non-alcoholic fatty liver disease

J Xu, J Shen, R Yuan, B Jia, Y Zhang… - Frontiers in …, 2021 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver
diseases worldwide, and its prevalence is still growing rapidly. However, the efficient …

Celastrol: a promising agent fighting against cardiovascular diseases

Z Li, J Zhang, X Duan, G Zhao, M Zhang - Antioxidants, 2022 - mdpi.com
Cardiovascular diseases (CVD) are leading causes of morbidity and mortality worldwide;
therefore, seeking effective therapeutics to reduce the global burden of CVD has become …

Anti-inflammatory agents as modulators of the inflammation in adipose tissue: A systematic review

SS da Cruz Nascimento, JL Carvalho de Queiroz… - PLoS …, 2022 - journals.plos.org
Obesity is characterized by an adipose tissue mass expansion that presents a risk to health,
associated with a chronic increase in circulating inflammatory mediators. Anti-inflammatory …

Mitochondrial Modulators: the defender

E Makinde, L Ma, GD Mellick, Y Feng - Biomolecules, 2023 - mdpi.com
Mitochondria are widely considered the “power hub” of the cell because of their pivotal roles
in energy metabolism and oxidative phosphorylation. However, beyond the production of …

[HTML][HTML] Analysis of the mechanism underlying diabetic wound healing acceleration by Calycosin-7-glycoside using network pharmacology and molecular docking

J Chen, H Ma, Y Meng, Q Liu, Y Wang, Y Lin, D Yang… - Phytomedicine, 2023 - Elsevier
Background Diabetic wounds represent a severe clinical challenge in which impaired M2
macrophage polarization and continuous macrophage glycolysis play crucial roles …